Crossmark

Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial

Crossref DOI link: https://doi.org/10.1136/lupus-2017-000206

Published Online: 2017-07-28

Published Print: 2017-07

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Bandyopadhyay, Somnath https://orcid.org/0000-0002-1269-5175
Connolly, Sean E

Jabado, Omar

Ye, June

Kelly, Sheila

Maldonado, Michael A

Westhovens, Rene

Nash, Peter

Merrill, Joan T

Townsend, Robert M
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct00119678 at ClinicalTrials.gov

Documents that mention this clinical trial

Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial
https://doi.org/10.1136/lupus-2017-000206
Funding

Funding for this research was provided by:

Bristol-Myers Squibb

Document is current

Any future updates will be listed below